RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report-Reference-Cited by-同舟云学术

RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report

Published:2017-04-11 Issue:1 Volume:30 Page:(vii)-(xviii)
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Suzuki Yasuo¹,Sugiyama Naonobu²,Fukuma Yuri²,Sugiyama Noriko³,Kokubo Takeshi³

Affiliation:

1. Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan;

2. Medical Affairs, Pfizer Japan Inc., Tokyo, Japan;

3. Development Japan, Pfizer Japan Inc., Tokyo, Japan

Funder

Pfizer Japan Inc.

Sawai Pharmaceutical Co., Ltd.

Shiono Chemical Co., Ltd.

Mitsubishi-Tanabe Pharma Corporation

Towa Pharmaceutical Co., Ltd.

Sandoz Co. Ltd.

Mitsubishi Tanabe Pharma Co. Ltd.

Ono Pharmaceutical Co. Ltd.

Astellas Pharma Inc.

Taisho-Toyama Pharmaceutical Co. Ltd.

Japan Blood Products Organization

Chugai Pharmaceutical Co. Ltd.

Ayumi Industry Co. Ltd.

Eisai Co. Ltd.

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14397595.2017.1304857

Reference30 articles.

1. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

2. Prospective study of methotrexate treatment for rheumatoid arthritis treated legitimately according to the government recommended 8 mg/week dose

3. Japan College of Rheumatology/Institute of Information Analysis. Studies on the effectiveness and safety of methotrexate (MTX) given at doses >8 mg/week: results from 3 RA patient cohort database studies in Japan (IORRA, REAL and NinJa) (in Japanese). Available from: https://www.ryumachi-jp.com/pdf/MTXHighdose.pdf [last accessed 18 Feb 2016].

4. Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased Serum 25(OH)D₃ Levels in Post-Menopausal Japanese Women with Osteoporosis after 3-Year Bisphosphonate Treatment;The Tohoku Journal of Experimental Medicine;2017